Last reviewed · How we verify
Entigin Film Coated Tablet 0.5mg
Entigin Film Coated Tablet 0.5mg is a Small molecule drug developed by Yung Shin Pharm. Ind. Co., Ltd.. It is currently FDA-approved.
At a glance
| Generic name | Entigin Film Coated Tablet 0.5mg |
|---|---|
| Sponsor | Yung Shin Pharm. Ind. Co., Ltd. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Entigin Film Coated Tablet 0.5mg CI brief — competitive landscape report
- Entigin Film Coated Tablet 0.5mg updates RSS · CI watch RSS
- Yung Shin Pharm. Ind. Co., Ltd. portfolio CI
Frequently asked questions about Entigin Film Coated Tablet 0.5mg
What is Entigin Film Coated Tablet 0.5mg?
Entigin Film Coated Tablet 0.5mg is a Small molecule drug developed by Yung Shin Pharm. Ind. Co., Ltd..
Who makes Entigin Film Coated Tablet 0.5mg?
Entigin Film Coated Tablet 0.5mg is developed and marketed by Yung Shin Pharm. Ind. Co., Ltd. (see full Yung Shin Pharm. Ind. Co., Ltd. pipeline at /company/yung-shin-pharm-ind-co-ltd).
What development phase is Entigin Film Coated Tablet 0.5mg in?
Entigin Film Coated Tablet 0.5mg is FDA-approved (marketed).